AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2019
Mar 4, 2019
29821_dirs_2019-03-04_6d2d1f3d-8167-4eb6-89d0-f171862adea0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-02-28
Reporting Person: Butcher Arthur C (SVP&Pres, Endoscopy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-28 | Common Stock | M | 1527.0000 | $0.0000 | Acquired | 14622.0000 | Direct |
| 2019-02-28 | Common Stock | F | 719.0000 | $40.1200 | Disposed | 13903.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-28 | Deferred Stock Units | $ | M | 1527.0000 | Disposed | 2022-02-28 | Common Stock (1527.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2559.0000 | Indirect |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.